|
|
Жизнь |
|
|
|
| ||||
Оценка влияния лечения эректильной дисфункции на качество жизни больныхЖивов Алексей Викторович Список литературы1. Бек А. Метод исследования риска аутоагрессивного поведения (шкала SSI) // Методики психологического исследования в клинике / под ред. Л.И. Вассермана. - Л:, 1978. - С. 102-105. 2. Великолуг А.Н. Социальные и клинико-психологические аспекты самоубийств в современном обществе / А.Н. Великолуг, А.Г. Амбрумова, Л.И. Постовалова // Обозрение психиатрии и мед. психологии. - 1997. - № 1. - С. 26-38. 3. Верткин А.Л. Распространенность и клиническое значение эректильной дисфункции у кардиологических больных / А.Л. Верткин, Ю.С. Тополянский, Е.В. Полупанова [и др.] // Консилиум медикум. - 2005. - Т. 7, № 7. - Электрон, ресурс. 4. Зотов М.В. Психофизиологические подходы к изучению, оценке и коррекции суицидальной настроенности при депрессивных и субдепрессивных состояниях // Материалы Всеармейской науч. конф. -СПб., 2001.-С. 24-26. 5. Зотов М.В. Внимание к мотивационно значимым стимулам как основа методического подхода к исследованию мотивации и его реализация на примере оценки суицидальных тенденций / М.В. Зотов, В.М. Петрукович // Современная психология: состояние и перспективы. - М., 2003. - Т. 1. - С. 264-266. 6. Каплан Г.И. Клиническая психиатрия : пер. с англ. : в 2 т. Т. 1 / Г.И. Каплан, Б.Дж. Сэдок. -М. : Медицина, 1994. - 673 с. 7. Карвасарский Б.Д. Неврозы / Б.Д. Карвасарский. - 2-е изд., пере-раб. и доп. - М.: Медицина, 1990. - 576 с. 8. Комолов Н.В. Оптимизация процесса психофизиологического сопровождения лечебного процесса психосоматических больных // Материалы Всеармейской науч. конф., посвящ. 5-летию кафедры военной психофизиологии ВМедА. - СПб., 2003. - С. 58-63. 9. Корзунин В.А. Сравнительная оценка профессионально важных качеств военных врачей в различных условиях деятельности // Материалы Всеармейской науч. конф., посвящ. 5-летию кафедры военной психофизиологии ВМедА. - СПб., 2003. - С. 102-107. 10. Лакин Г.Ф. Биометрия / Г.Ф. Лакин. - Изд. 4-е, перераб. и доп. -М. : Высш. шк., 1990. - 352 с. 11. Литвинцев С.В. Диагностика и профилактика суицидального поведения военнослужащих. (Сообщение 2-е) / СВ. Литвинцев, В.К. Шамрей, В.В. Нечипоренко, И.Г. Попик // Воен.-мед. журн. — 2001.-№9.-С. 22-29. 12. Личко А.Е. Медико-психологическое обследование соматических больных / А.Е. Личко, Н.Я. Иванов // Журн. невропатологии и психиатрии. - 1980. - Вып. 8. - С 1195-1198. 13. Личко А.Е. Методы медико-психологической диагностики соматических больных / А.Е. Личко, Н.Я. Иванов. - Л., 1983. - 208 с. Н.Лоран О.Б. Климактерические расстройства у мужчин / О.Б. Лоран, А.С Сегал. - М.: OGGI Production, 1998. - 88 с. 15. Маклаков А.Г. Военная психология / под ред. А.Г. Маклакова. -СПб., 2005. - 463 с. 16. Методы исследования в психологии / под ред. Л.И. Вассермана. -СПб., 2001.-334 с. 17. Нечипоренко В.В. Медицинские аспекты агрессивного и суицидального поведения // Военная психиатрия. - СПб., 2001. -С 298-310. 18. Новиков B.C. Теоретические и прикладные основы профессионально-психологического отбора военнослужащих : руководство / B.C. Новиков, А.А. Боченков. - СПб.: ВМедА, 1998. - 188 с. 19. Петрукович В.М. Использования регистрации резервов внимания в диагностике нервно-психической устойчивости человека / В.М. Петрукович, М.В. Зотов // Материалы науч. конф. / ВмедА. -СПб., 2001.-С. 45-46. 20. Попов Ю.В. Система шкал социальной дезадаптации (ШСД) патохарактерологического диагностического опросника для подростков / Ю.В. Попов, Н.Я. Иванов // Саморазрушающее поведение у подростков : сб. науч. тр. - Л., 1991. - С. 118-122. 21. Рейнольде Дж. Методика оценки суицидального риска : (вопросник ASIQ) // Методы исследования в психологии / под ред. Л.И. Вассермана. - М.5 1991. - С. 91-93. 22. Симонов П.В. Эмоциональный мозг / П.В. Симонов. - М. : Наука, 1981.-216 с. 23. Собчик Л.Н. Методы психологической диагностики : метод, руководство. Вып. 1 / Л.Н. Собчик. - М. : Б. и., 1990. - 73 с. 24. Чермянин СВ. Психофизиологическое обеспечение боевой деятельности военнослужащих в условиях локальных войн : автореф. дис. ... д-ра мед. наук / СВ. Чермянин. - СПб., 1998. - 48 с. 25. Щеплев П.А. Реконструктивная и эстетическая хирургия полового члена : автореф. дис. ... д-ра мед. наук / П.А. Щеплев. - М., 1996. -58 с. 26. Abolfotouh M.A. Effect of erectile dysfunction on quality of life / M.A. Abolfotouh, N.S. al-Helali // East Mediterr Health J. - 2001. -Vol. 7,N3.-P. 510-518. 27. Althof S.E. EDITS: Development of questionnaires for evaluating satisfaction with treatments for erectile dysfunction / S.E. Althof, E.W. Corty, S.B. Levine [et al.] // Urology. - 1999. - Vol. 53, N 4. -P. 793-799. 28. Althof S.E. Treatment responsiveness of the self-esteem and relationship questionnaire in erectile dysfunction / S.E. Althof, J.C. Cappelleri, A. Shpilsky [et al.] // Urology. - 2003. - Vol. 61, N 5. - P. 888-892. 29. AUA guideline on the management of erectile dysfunction: diagnosis and treatment recommendations. - Baltimore : American Urological Association, 2005. - 253 p. 30. Auerbach S.M. Simultaneous administration of vardenafil and tamsu-losin does not induce clinically significant hypotension in patients with benign prostatic hyperplasia / S.M. Auerbach, M. Gittelman, A. Mazzu [et al.] // Urology. - 2004. - Vol. 64, N 5. - P. 998-1003. 31. Baldwin K. Under-reporting of erectile dysfunction among men with unrelated urologic conditions / K. Baldwin, P. Ginsberg, R.C. Harkaway // Intern. J. Impot. Res. - 2003. - Vol. 15, N 2. - P. 87-89. 32. Barada J. Successful salvage of sildenafil (Viagra) failures: benefits of patient education and rechallenge with sildenafil // Intern. J. Imp. Res. - 2001. - Vol. 13, suppl. 4. - P. 49. 33. Benevides M.D. Intraurethral application of alprostadil in patients with failed inflatable penile prosthesis / M.D. Benevides, C.C. Carson // J. Urol. -2000. -Vol. 163, N 3. -P. 785-787. 34. Beutel M.E. Epidemiology of sexual dysfunction in the male population / M.E. Beutel, W. Weidner, E. Brahler // Andrologia. - 2006. -Vol. 38,N4.-P. 115-121. 35. Blander D.S. Sex inventories: can questionnaires replace erectile dysfunction testing? / D.S. Blander, R.F. Sanchez-Ortiz, G.A. Broderick // Urology. - 1999. - Vol. 54, N 4. - P. 719-723. 36. Brant M.D. The prosthesis salvage operation: immediate replacement of the infected penile prosthesis / M.D. Brant, J.K. Ludlow, J J. Mulcahy//J. Urol. -1996. -Vol. 155,N1.-P. 155-157. 37. Broderick G.A. Changing practice patterns in erectile dysfunction: a diagnostic algorithm for the new millennium // Adv. Ren. Repl. Ther. - 1999.-Vol. 65N 4.-P. 314-326. 38. Broderick G.A. Color duplex doppler ultrasound: penile blood flow study // Male infertility and sexual dysfunction / by ed. WJ.G. Hellstrom. -New York [etc.], 1997. - Chap. 27. - P. 367-396. 39. Broderick G.A. ED assessment: which patient needs testing and what's useful // Current and future strategies in erectile dysfunction management : AUA postgraduate course. - Baltimore, 2004. - 68 p. 40. Broderick G.A. Management of patients with Peyronie's disease // Male sexual dysfunction : Practical management guidelines. AUA postgraduate course. - Baltimore, 2006. - 46 p. 41.Buvat J. Acceptance, efficacy and preference of sildenafil in patients on long term auto-intracavernosal therapy: a study with follow-up at one year / J. Buvat, A. Lemaire, J. Ratajczyk // Intern. J. Imp. Res. -2002. - Vol. 14, N 6. - P. 483-486. 42. Capelleri J.C. Comparison between sildenafil-treated subjects with erectile dysfunction and control subjects on the self-esteem and relationship questionnaire / J.C. Capelleri, S.S. Bell, S.E. Althof [et al.] // J. Sex. Med. - 2006. - Vol. 3, N 2. - P. 274-282. 43. Carson C.C. Management of prosthesis infections in urologic surgery // Urol. Clin. North. Amer. - 1999. - Vol. 26, N 4. - P. 829-839. 44. Carson C.C. What to do when initial PDE5 inhibitor therapy fails // Contemporary Urology. - 2006. -N 5. - P. 55-65. 45. Carson C.C. The efficacy of sildenafil citrate (Viagra®) in clinical populations: an update / C.C. Carson, L. Burnet [et al.] // Urology. -2002. - Vol. 60, N 2, suppl. 2. - P. 12-27. 46. Carson С.С. Urologic prostheses : the complete practical guide to devices, their implantation, and patient follow-up / ed. C.C. Carson. -New Jersey : Humana press, 2002. - 309 p. 47. Carson C.C. Erectile response with vardenafil in sildenafil nonre-sponders: a multi-centre, double blind, 12-week, flexible dose, placebo-controlled, erectile dysfunction clinical trial / C.C. Carson, D.G. Hatzicristou, S. Carrier [et al.] // Brit. J. Urol. - 2004. - Vol. 94, N9.-P. 1301-1309. 48. Carson C.C. Phosphodiesterase type 5 inhibitors for erectile dysfunction / C.C. Carson, T.F. Lue // BJU Int. - 2005. - Vol. 96, N 3. - P. 257-280. 49. Carson C.C. Efficacy, safety, and treatment satisfaction of tadalafil versus placebo in patients with erectile dysfunction evaluated at tertiary-care academic centers / C.C. Carson,.R. Shabsigh, S. Segal [et al.] // Urology. - 2005. - Vol. 65, N 2. - P. 353-359. 50. Chiang H.S. 10 years of experience with penile prosthesis implantation in Taiwanese patients / H.S. Chiang, C.C. Wu, T.C. Wen // J. Urol. -2000. - Vol. 163, N 2. - P. 476^80. 51. Cochlin D.L. Urogenital ultrasound : a text atlas / ed. D.L. Cochlin. -New York : Martin Dunitz, 1996. - 375 p. 52. Cookson M.S. Long-term results with vacuum constriction device / M.S. Cookson, P.V.Nadig // I Urol. - 1993. - Vol. 149, N 2. - P. 290-294. 53. Costa P. Erectile dysfunction: knowledge, wishes and attitudes. Results of a French study of 5.099 men aged 17 to 70 / P. Costa, С Avances, L. Wagner // Prog. Urol. - 2003. - Vol. 13, N 2. - P. 85-91. 54. Costabile R.A. Oral trazodone is not effective therapy for erectile dysfunction: a double-blind, placebo controlled trial / R.A. Costabile, M. Spevak // J. Urol. - 1999. - Vol. 161, N 6. -P. 1819-1822. 55. Davis-Joseph B. Accuracy of the initial history and physical examination to establish the etiology of erectile dysfunction / B. Davis-Joseph, L. Tiefer, A. Melman // Urology. - 1995. -Vol. 45, N 3. - P. 498-502. 56. De Boer BJ. Erectile dysfunction in primary care: prevalence and patient characteristics: The ENIGMA study / B.J. De Boer, MiL. Bots, A. Lycklama [et al.] // Intern. J. Impot. Res. - 2004. - Vol. 16, N 3. -P. 214-219. 57. De Rose A.F. Combined oral therapy with sildenafil and doxazosin for the treatment of non-organic erectile dysfunction refractory to sildenafil monotherapy / A.F. De Rose, M. Giglio, P. Traverso [et al.] // Intern. J. Imp. Res. - 2002. - Vol. 14, N 1. - P. 50-53. 58. De Tejada LS. Therapeutic strategies for optimizing PDE-5 inhibitor therapy in patients with erectile dysfunction considered difficult or challenging to treat // Intern. J. Imp. Res. - 2004. - Vol. 16, suppl. 1. -P. 40-42. 59. Dean J. Erectile dysfunction and sexual satisfaction: new perspectives / J. Dean, B.-J. de Boer, A. Grazziotin [et al.] // Europ. Urol. - 2006. -Vol. 5,N 13, suppl. -P. 759-760. 60. Dean J. Effective erectile dysfunction (ED) treatment enables men to enjoy better sex: the importance of erectile hardness, psychological well-being, and partner satisfaction / J. Dean, B.-J. de Boer, A. Graziottin [et al.] // Europ. Urol. - 2006. - Vol. 5, N 13, suppl. - P. 761-766. 61. Dean J. Partner satisfaction and successful treatment outcomes for men with erectile dysfunction / J. Dean, B.-J. de Boer, A. Graziottin [et al.] Europ. Urol. - 2006. - Vol. 5, N 13, suppl. - P. 779-785. 62. Dean J. Psychological, social and behavioral benefits for men following effective erectile dysfunction (ED) treatment: men who enjoy better sex experience improved psychological well-being / J. Dean, B.-J. de Boer, A. Graziottin [et al.] // Europ. Urol. - 2006. - Vol. 5, N 13, suppl.-P. 773-778. 63. Dean J. The role of erection hardness in determining erectile dysfunction (ED) treatment outcome / J. Dean, B.-J. de Boer, A. Graziottin [et al.] // Europ. Urol. - 2006. - Vol. 5, N 13, suppl. - P. 767-772. 64. DeBusk R. Management of sexual dysfunction in patients with cardiovascular disease : recommendations of the Princeton Consensus Panel / R. DeBusk, Y. Drory, I. Goldstein [et al.] // Amer. J. Cardiol. - 2000. - Vol. 86, N 2A. - P. 62F-68F. 65. Derby С A. Modifiable risk factors and erectile dysfunction: can lifestyle changes modify risk? / C.A. Derby, B.A. Mohr, I. Goldstein [et al.] // Urology. - 2000. - Vol. 56, N 2. - P. 302-306. 66. Dula E. Double-blind, crossover comparison of 3 mg apomorphine SL with placebo and with 4 mg apomorphine SL in male erectile dysfunction / E. Dula, S. Bukofzer, R. Perdok, M. George // Europ. Urol. -2001. -Vol. 39, N 5. - P. 558-553. 67. Eardley I. An open-label, randomized, flexible-dose, crossover study to assess the comparative efficacy and safety of sildenafil citrate and apomorphine hydrochloride in men with erectile dysfunction / I. Eardley, P. Wright, R. MacDonagh [et al.] // BJU Int. - 2004. - Vol. 93, N9.-P. 1271-1275. 68. Eardley I. Attitudes toward treatment of erectile dysfunction: results from the MALES study /1. Eardley, R. Rosen, W. Fisher [et al.] // Cur. Med. Res. Opin. -2004. - Vol. 20, N 5. -P. 607-615. 69. Eid J.F. Multicomponent inflatable penile prosthesis: keys to success // Contemp. Urol. -2003. -N 6. -P. 36-48. 70. Feldman H.A. Impotence and it's medical and psychosocial correlates: results of the Massachusetts Male Aging Study / H.A. Feldman, I. Goldstein, D.G. Hatzichristou [et al.] // J. Urol. - 1994. - Vol. 151, N1.-P. 54-61. 71.Flynn RJ. Long-term follow-up of patients with erectile dysfunction commenced on self injection with intracavernosal papaverine with or without phentolamine / RJ. Flynn, G. Williams // Brit. J. Urol. - 1996. -Vol. 78,N4.-P. 628-631. 72. Fulgham P.F. Disappointing initial results with transurethral alprosta-dil for erectile dysfunction in a urology practice setting /P.F. Fulgham, J.S. Cochran, J.L. Denman [et al.] // J. Urol. - 1998. - Vol. 160, N 6, pt. 1.-P. 2041-2046. 73. Gee W.F. Practice trends of American urologists in the treatment of impotence, incontinence and infertility / W.F. Gee, H.L. Holtgrewe, P.C. Albertsen [et al.] // J. Urol. - 1996. - Vol. 156, N 5. - P. 1778-1780. 74. Greco A.E. Combining testosterone and PDE5 inhibitors in erectile dysfunction: basic rationale and clinical evidences / A.E. Greco, G. Spera, A. Aversa // Europ. Urol. - 2006. - Vol. 50, N 5. - P. 940-947. 75. Guay A.T. Optimizing response to phosphodiesterase therapy: impact of risk-factor management // J. Androl. - 2003. - Vol. 24, N 6. - P. 59-62. 76. Guay A.T. Clinical experience with intraurethral alrostadil (MUSE) in the treatment of men with erectile dysfunction: a retrospective study. Medicated urethral system for erection / A.T. Guay, J.B. Perez, E. Velasquez [et al.] // Europ. Urol. - 2000. - Vol. 38, N 6. - P. 671-676. 77. Gupta R. Predictors of success and risk factors for attrition in the use of intracavernous injection / R. Gupta, J. Kirschen, R.C. Barrow, 2nd, J.F J. Eid // Urology. - 1997. - Vol. 157, N 5. - P. 1681-1686. 78. Hatzichristou D. Diagnostic steps in the evaluation of patients with erectile dysfunction / D. Hatzichristou, K. Hatzimouratidis, M. Bekas [et al.] // J. Urol. - 2002. - Vol. 168, N 2. - P. 615-620. 79. Hatzichristou D.G. Hemodynamic characterization of a functional erection. Arterial and corporeal veno-occlusive function in patients with a positive intracavernosal injection test / D.G. Hatzichristou, K. Hatzimouratidis, A. Apostolidis [et al.] // Europ. Urol. - 1999. -Vol. 36, N1.-P. 60-67. 80. Hatzichristou D.G. Sildenafil versus intracavernous injection therapy: efficacy and preference in patients on intracavernous injection for more than 1 year / D.G. Hatzichristou, A. Apostolidis, V. Tzortzis [et al.]//J. Urol. - 2000. - Vol. 164, N4.-P. 1197-1200. 81. Hatzichristou D.G. Nocturnal penile tumescence and rigidity monitoring in young potent volunteers: reproducibility, evaluation criteria and the effect of sexual intercourse / D.G. Hatzichristou, K. Hatzimouratidis, E. Ioannides [et al.] // J. Urol. - 1998. - Vol. 159, N6.-P. 1921-1926. 82. Hatzichristou D.G. Current treatments and emerging therapeutic approaches in male erectile dysfunction / D.G. Hatzichristou, E.S. Pescatori // BJU Int. - 2001. - Vol. 88, suppl. 3. - P. 11-17. 83. Heaton J.P. Intracavernosal alprostadil is effective for the treatment of erectile dysfunction in diabetic men / J.P. Heaton, D. Lording, S.N. Liu [et al.] // Intern. J. Impot Res. - 2001. - Vol. 13, N 6. - P. 317-321. 84. Hedon F. Anxiety and erectile dysfunction: a global approach to ED enhances results and quality of life // Intern. J. Impot. Res. - 2003. -Vol. 15,suppl.2.-P. 16-19. 85. Hellstrom WJ. Sustained efficacy and' tolerability of vardenafil, a highly potent selective phosphodiesterase type 5 inhibitor, in men with erectile dysfunction: results of a randomized, double-blind, 26-week placebo-controlled pivotal trial / WJ. Hellstrom, M. Gittelman, G. Karlin [et al.] // Urology. - 2003. - Vol. 61, N 4, suppl. 1. - P. 8-14. 86. Jiann B.P. Compliance of sildenafil treatment for erectile dysfunction and factors affecting it / B.P. Jiann, C.C. Yu, C.C. Su, J.Y. Tsai // Intern. J. Impot. Res. - 2006. - Vol. 18, N 2. - P. 146-149. 87. Jockenhovel F. Testosterone therapy - what, when and to whom // Aging male. - 2004. - VoL 7, N 4. - P. 319-324. 88. Kattan S. Double-blind randomized crossover study comparing intra-corporeal prostaglandin El with combination of prostaglandin El and lidocaine in the treatment of organic impotence // Urology. - 1995. -Vol. 45,N6.-P. 1032-1036. 89. Kloner R.A. Interaction between the phosphodiesterase 5 inhibitor, ta-dalafil and 2 alpha-blockers, doxazosin and tamsulosin in healthy normotensive men / R.A. Kloner, G. Jackson, J.T. Emmick [et al.] // J. Urol. - 2004. - Vol. 172, N 5, pt. 1. - P. 1935-1940. 90. Kupelian V. Is there a relationship between sex hormones and erectile dysfunction? Results from the Massachusetts Male Aging Study / V. Kupelian, R. Shabshigh, T. Travison [et al.] // J. Urol. - 2006. -Vol. 176, N 6. - P. 2584-2588. 91.Lakin M.M. Intracavernous injection therapy: analysis of results and complications / M.M. Lakin, D.K. Montague, S. VanderBrug Meden-dorp [et al.] // J. Urol. - 1990. - Vol. 143, N 6. - P. 1138-1141. 92. Laumann E.O. The epidemiology of erectile dysfunction: results from the National Health and Social Life Survey / E.O. Laumann, A. Paik, R.C. Rosen // Intern. J. Impot. Res. - 1999. - Vol. 11, suppl 1. - P. 60-64. 93. Lee T. Paraffinoma of the penis / T. Lee, H.R. Choi, T.L Lee, H.Y. Lee // Yonsei Med. J. - 1994. - Vol. 35, N 3. - P. 344-348. 94. Leungwattanakij S. Intracavernosal injection and intraurethral therapy for erectile dysfunction / S. Leungwattanakij, V. Flynn, jr, W.J. Hellstrom // Urol. Clin. North. Amer. - 2001. - Vol. 28, N 2. - P. 343-354. 95.Levine L.A. Vacuum constriction and external erection devices in erectile dysfunction / L.A. Levine, R.G. Dimitriou // Urol. Clin. North. Amer. -2001. -Vol. 28,N2. -P. 335-341. 96. Levine L.A. Mechanical reliability and safety of, and patient satisfaction with the Ambicor inflatable penile prosthesis: results of a 2 center study / L.A. Levine, C.R. Estrada, A J. Morgentaler // Urology. -2001.-Vol. 166,N3.-P. 932-937. 97. Lewis R.W. The MUSE-ACTIS Study Group. Combined use of tran-surethral alprostadil and an adjustable penile constriction band in men with erectile dysfunction: results from a multicentre trial / R.W. Lewis, K. Weldon, K. Nemo // Intern. J. Impot. Res. - 1998. - Vol. 10, suppl. -P. 49. 98. Lewis R.W. External vacuum therapy for erectile dysfunction: use and results / R.W. Lewis, R. Witherington // World J. Urol. - 1997. - Vol. 15,N1.-P. 78-82. 99. Linet O.I. Efficacy and safety of intracavernosal alprostadil in men with erectile dysfunction / O.I. Linet, F.G. Ogrinc // N. Engl. J. Med. -1996. - Vol. 334, N 14. - P. 873-877. 100. Lizza E.F. Definition and classification of erectile dysfunction : report of the Nomenclature Committee of the International Society of Impotence Research / E.F. Lizza, R.C. Rosen // Intern. J. Impot. Res. — 1999.-Vol. 11,N3.-P. 141-143. 101. Lue T.F. Summary of the recommendations on sexual dysfunctions in men / T.F. Lue, F. Giuliano, F. Montorsi, R.C. Rosen [et al.] // J. Sex. Med. - 2004. - Vol. 1, N 1. - P. 6-23. 102. Lue T.F. Vasculogenic impotence evaluated by high-resolution ul-trasonography and pulsed Doppler spectrum analysis / T.F. Lue, H. Hricak, R.W. Marich [et al.] // Radiology. - 1985. - Vol. 155, N 3. -P. 777-781. 103. Lyngdorf P. Epidemiology study of erectile dysfunction and it's risk factors: a practice based study in Denmark / P. Lyngdorf, L. Hemmingsen // Intern. J. Impot. Res. - 2004. - Vol. 16, N 2. - P. 105-111. 104. Mallis D. Moderate and severe erectile dysfunction equally affects life satisfaction / D. Mallis, K. Moisidis, P.S. Kirana [et al.] // J. Sex. Med. - 2006. - Vol. 3, N 3. - P. 442-449. 105. Martinez R. Clinical experience with apomorphine hydrochloride: the first 107 patients / R.Martinez, A. Puigvert, J.M. Pomerol, R. Rodriguez-Villalba // J. Urol. - 2003. - Vol. 170, N 6, pt. 1. - P. 2352-2355. 106. McAninch J.W. Reconstruction of extensive urethral strictures: circular fasciocutaneous penile flap // J Urol. - 1993. - Vol .149, N 3. -P. 488-491 . 107. McCullough A.R. Achieving treatment optimization with sildenafil citrate (Viagra) in patients with erectile dysfunction / A.R. McCullough, J.H. Barada, A. Fawzy [et al.] // Urology. - 2002. -Vol. 60, N 2, suppl. 2. - P. 28-38. 108. McVary K.T. Sildenafil effects on clinical lower urinary tract symptoms. Presentation at: The Annual Meeting of the Sexual Medicine Society of North America, November 21st, 2005, New York, NY, USA. 109. Meares E.M. Bacteriologic localization patterns in bacterial prosta-titis and urethritis / E.M. Meares, T.A. Stamey // Invest. Urol. - 1968. -Vol. 5,N5.-P. 492-518. 110. Meuleman EJ. Investigation of erectile dysfunction. Diagnostic testing for vascular factors in erectile dysfunction / EJ. Meuleman, W.L. Diemont // Urol. Clin. North. Amer. - 1995. - Vol. 22, N 4. -P. 803-819. 111. Michal V. R. Histological changes An the penile arterial bed with aging and diabetes // Vasculogenic Impotence: Proceedings of the First International Conference on Corpus Cavernosum Revascularization / ed. by A. Zorgniotti and G. Rossi. - Springfield, 1980. - P! 113-119. 112. Mobley D.F. Office evaluation of the impotent man / D.F. Mobley, N.H. Baum // Textbook of andrology / ed. W.J.G. Hellstrom:, - New York : Springer, 1997.-P. 167-185. 113. Montague D. Penile prosthesis in the year 2000 / D.Montague, K. Angermeier. - Baltimore : American Urological Association, 2001. - 38 p. - (AUA Update series. Lesson 31 ; Vol. 19). 114. Montorsi F. Treatment satisfaction in patients with erectile dysfunction switching from prostaglandin E(l) intracavernosal injection therapy to oral sildenafil citrate / F. Montorsi, S.E. Althof, M. Sweeney [et al.] // Intern. J. Imp. Res. - 2003. - Vol. 15, N 6. - P. 444-449:. 115. Montorsi F. Efficacy and safety of fixed-dose oral sildenafil in the treatment of erectile dysfunction of various etiologies / F. Montorsi, Т.Е. McDermott, R. Morgan [et al.] // Urology. - 1999. - Vol. 53, N 5. -P. 1011-1018. 116. Montorsi F. AMS three-piece inflatable implants for erectile dysfunction: a long-term multi-institutional study in 200 consecutive patients / F. Montorsi, P. Rigatti, G. Carmignani [et al.] // Europ. Urol. -2000. -Vol. 37,N 1.-P. 50-55. 117. Montorsi F. The ageing male and erectile dysfunction / F. Montorsi, A. Salonia, F. Deho [et al.] // World J. Urol. - 2002. - Vol. 20, N 1. -P. 28-35. 118. Moore T.M. Erectile dysfunction in early, middle, and late adulthood: symptom patterns and psychosocial correlates / T.M. Moore, J.L. Strauss, S. Herman, C.F. Donatucci // J. Sex. Marital. Ther. -2003. -Vol. 29, N 5. - P. 381-399. 119. Morales A. Hormonal erectile dysfunction: evaluation and management / A. Morales, J.P. Heaton // Urol. Clin. North Amer. - 2001. -Vol. 28, N. 2.-P. 279-288. 120. Moriel E.Z. Sodium bicarbonate alleviates penile pain induced by intracavernous injections for erectile dysfunction / E.Z. Moriel, J. Rajfer // J. Urol. - 1993. - Vol. 149, N 5, pt. 2. - P. 1299-1300. 121. Moyad M.A. Prevention and treatment of erectile dysfunction using lifestyle changes and dietary supplements: what works and what is worthless. Pt. 2 / M.A. Moyad, J.H. Barada, T.F. Lue [et al.] // Urol. Clin. North Amer. - 2004. - Vol. 31, N 2. - P. 259-273. 122. Moyad MA. Prevention and treatment of erectile dysfunction using lifestyle changes and dietary supplements: what works and what is worthless. Pt. 1 / M.A. Moyad, J.H. Barada, T.F. Lue [et al.] // Urol. Clin. North Amer. - 2004. - Vol. 31, N 2. - P. 249-257. 123. Mulcahy J.J. Long term experience of salvage of infected penile implants // J. Urol. - 2000. - Vol. 163, N 2. - P. 481-482. 124. Mulcahy J.J. Prevention and correction of penile implant problems // Management of complex penile implant cases Symposium : AUA Annual Meeting handbook. - Baltimore, 1995. - 53 p. 125. Mulhall J.P. Analysis of the consistency of intraurethral pros-taglandin E(l) (MUSE) during at-home use / J.P. Mulhall, A.E. Jahoda, A. Ahmed, M. Parker // Urology. - 2001. - Vol. 58, N 2. -P. 262-266. 126. Munarriz R.M. Experience with the Mentor a-1 / R.M. Munarriz, I. Goldstein // Urologic prostheses : the complete practical guide to devices, their implantation, and patient;follow-up / ed. C.C. Carson. -New Jersey : Humana press, 2002. -P. 191-199. 127. Murad Basar M. A classification based on peak systolic velocity and end diastolic velocity predicts sildenafil citrate success / M. Murad Basar, A. Atan, U.Y. Tekdogan, E. Batislam // Scand. J. Urol. Nephrol. - 2003. - Vol. 37, N 6. - P. 502-506. 128. Mydlo J.H. Use of combined extracorporeal injection and a phos-phodiesterase-5 inhibitor therapy for men with a suboptimal response to sildenafil and/or vardenafil monotherapy after radical retropubic prostatectomy / J.H. Mydlo, R. Viterbo, P/ Crispen // BJU Int. - 2005. -Vol. 95,N6.-P. 843-846. 129. Mydlo J.H. Results from different patient populations using combined therapy with alprostadil and sildenafil: predictors of satisfaction / J.H. Mydlo, M.A. Volpe, RJ. MacChia // BJU Int. - 2000. - Vol. 86, N4.-P. 469-473. 130. Nehra A. Rationale for combination therapy of intraurethral pros-taglandin E(l) and sildenafil in the salvage of erectile dysfunction patients desiring noninvasive therapy / A. Nehra, M.L. Blute, D.M. Barrett [et al.] // Intern. J. Imp. Res. - 2002. - Vol. 14, suppl 1. -P. 38^2. 131. Nickel J.C. Research guidelines for chronic prostatitis : consensus report from the first National Institutes of Health International Prostatitis Collaborative Network / J.C. Nickel, L.M. Nyberg, M. Hennenfent // Urology. - 1999. - Vol. 54, N 2. - P. 229-233. 132. NIH Consensus Conference. Impotence. Consensus development panel on impotence // JAMA. - 1993. - Vol. 270, N 1. - P. 83-90. 133. Nolazco C. Prevalence of sexual dysfunctions in Argentina / C. Nolazco, O. Bellora, M. Lopez [et al.] // Intern. J. Imp. Res. - 2004. -Vol. 16, N 1. - P. 69-72. 134. Oesterling J.E. Influence of patient age on the serum PSA concentration: an important clinical observation / J.E. Oesterling, W.H. Cooner, SJ. Jacobsen [et al.] // Urol. Clin. North Amer. - 1993. -Vol. 20,N4.-P. 671-680. 135. Okulate G. Erectile dysfunction: prevalence and relationship to depression, alcohol abuse and panic disorder / G. Okulate, O: Olayinka, A.S. Dogunro // Gen. Hosp. Psych. - 2003. - Vol. 25, N 3. - P. 209-213. 136. Padma-Nathan H. Treatment of men with erectile dysfunction with transurethral alprostadil. Medicated Urethral System for Erection (MUSE) Study Group [see comments] / H. Padma-Nathan, WJ. Hellstrom, F.E. Kaiser [et al.] // New Engl. J. Med. - 1997. -Vol. 336, N1.-P. 1-7. 137. Park K. Risk factors in predicting a poor response to sildenafil citrate in elderly men with erectile dysfunction / K. Park, J.H. Ku, S.W. Kim, J.S. Paick // BJU Int. - 2005. - Vol. 95, N 3. - P. 66-70. 138. Perelman M.A. Sex coaching for physicians: combination treatment for patient and partner // Intern. J. Impot. Res. - 2003. - Vol. 15, suppl. 5.-P. 67-74. 139. Perimenis P. A comparative, crossover study of the efficacy and safety of sildenafil and apomorphine in men with evidence of arterio-genic erectile dysfunction / P/ Perimenis, K. Gyftopoulos, K. Giannitsas [et al.] // Intern. J. Impot. Res. - 2004. - Vol. 16, N 1. -P. 2-7. 140. Porst H. The rationale for prostaglandin El in erectile failure: a survey of worldwide experience // J. Urol. - 1996. - Vol. 155, N3.-P. 802-815. 141. Posner M. Chronometric exploration of mind / M. Posner. — New York ; Oxford : Oxford University Press, 1986. - 124 p. 142. Raina R. Long-term intracavernous therapy responders can potentially switch to sildenafil citrate after radical prostatectomy / R. Raina, M.M. Lakin, A. Agarwal [et al.] // Urology. - 2004. - Vol. 63, N 3. -P. 532-537. -Discussion: p. 538. 143. Rajpurkar A. Comparison of satisfaction rates and erectile function in patients treated with sildenafil, intracavernous prostaglandin El and penile implant surgery for erectile dysfunction in urology practice / A. Rajpurkar, C.B. Dhabuwala // J. Urol. - 2003. - Vol. 170, N 1. -P. 159-163. 144. Rao D.S. Vasculogenic impotence. Arterial and venous surgery / D.S. Rao, C.F. Donatucci // Urol. Clin. North. Amer. - 2001. - Vol. 28, N2.-P. 309-319. 145. Rosen R. Sensitivity of the psychological and interpersonal relationship scales to oral therapies for erectile dysfunction / R. Rosen, G. Broderick, R. Shabsigh [et al.] // J. Sex. Med. - 2005. - Vol. 2, N 4. -P. 461-468. 146. Rosen R.C. Psychogenic erectile dysfunction: classification and management // Urol. Clin. North. Amer. - 2001. - Vol. 28, N 2. -P.269-278. 147. Rosen R.C. Development and evaluation of an abridged, 5-item version of the International Index of Erectile Function (IEEF-5) as a diagnostic tool for erectile dysfunction / R.C. Rosen, J.C. Cappelleri, M.D. Smith [et al.] // Intern. J. Impot. Res. - 1999. - N 11. - P. 319-326. 148. Rosen R.C. Quality of life, mood, and sexual function: a path analytic model of treatment effects in men with erectile dysfunction and depressive symptoms / R.C. Rosen, S.N. Seidman, M.A. Menza [et al.] // Intern. J. Impot. Res. - 2004. - Vol. 16, N 4. - 334-340. 149. Sairam K. Sildenafil influences lower urinary tract symptoms / K. Sairam, E. Kulinskaya, T.A. McNicholas [et al.] // Brit. J. Urol. Int. - 2002. - Vol. 90, N 9. - P. 836-839. 150. Sanchez de la Vega J. Erectile dysfunction in those under 40: etio-logical and contributing factors / J. Sanchez de la Vega, J. Amaya Gutierrez, J.J. Alonso Flores, M. Garcia Perez // Arch. Esp. Urol. -2003. - Vol. 56, N3.-P. 161-164. 151. Sanchez-Cruz J.J. Male erectile dysfunction and health-related quality of life / JJ. Sanchez-Cruz, A. Cabrera-Leon, A. Martin-Morales [et al.] // Europ. Urol. - 2003. - Vol. 44, N 2. - P. 245-253. 152. Sargin S. Dynamic cavernosography in the evaluation of impotence / S. Sargin, A. Esen, A. Ergen [et al.] // Intern. Urol. Nephrol. - 1991. -Vol. 23, N6.-P. 599-604. 153. Sasayama S. Men's health study: current status of erectile dysfunction of 6,112 ambulatory patients at general practitioners offices in Japan / S. Sasayama, N. Ishii, F. Ishikura [et al.] // J. Cardiol. - 2003. -Vol. 42,N2.-P. 57-65. 154. Schwartz E.J. Sildenafil preserves intracorporeal smooth muscle after radical retropubic prostatectomy / EJ. Schwartz, P. Wong, R.G. Graydon // J. Urol. - 2004. - Vol. 162, N 2, pt. 1. - P. 111-11 A. 155. Scott F.B. Management of erectile impotence: use of implantable inflatable prosthesis / F.B. Scott, W.E. Bradley, D.W. Timm // Urology. - 1973. - Vol. 2, N 1. -P. 80-83. 156. Seftel A.D. Erectile dysfunction in the elderly: epidemiology, etiology and approaches to treatment // J. Urol. - 2003. - Vol. 169, N 6. -P. 1999-2007. 157. Shabshigh R. Randomized study of testosterone gel as adjunctive therapy to sildenafil in hypogonadal men with erectile dysfunction who do not respond to sildenafil alone / R. Shabshigh, J.M. Kaufman, C. Steidle [et al.] // J. Urol. - 2004. - Vol. 172, N 2. - P. 658-663. 158. Shiri R. Prevalence and severity of erectile dysfunction in 50 to 75-year-old Finnish men / R. Shiri, J. Koskimaki, M. Hakama [et al.] // J. Urol. - 2003. - Vol. 170, N 6. - P. 2342-2344. 159. Small M.P. Small carrion penile prosthesis: a new implant for the management of impotence / M.P. Small, H.M. Carrion, J.A. Gordon // Urology. - 1975. - Vol. 5, N 4. - P. 479-486. 160. Stamogiannou I. Beliefs about illness and quality of life among men with erectile dysfunction / I. Stamogiannou, E.A. Grunfeld, K. Denison, G. Muir // Intern. J. Impot. Res. - 2005. - Vol. 17, N 2. -P. 142-147. 161. Stanley G.E. Penile prosthetic trends in the era of effective oral erectogenic agents / G.E. Stanley, TJ. Bivalacqua, W.J. Hellstrom // South Med. J. - 2000. - Vol. 76, N 12. - P. 1153-1156. 162. Suetomi T. Evaluation of the effectiveness of sildenafil using questionnaire methods versus audio-visual sexual stimulation / T. Suetomi, F. Endo, H. Takeshima, H. Akaza // Intern. J. Urol. - 2005. - Vol. 12, N4.-P. 369-373. 163. Sundaram C.P. Long-term follow-up of patients receiving injection therapy for erectile dysfunction / C.P. Sundaram, W. Thomas, L.E. Pryor [et al.] // Urology. - 1997. -Vol. 49, N 6. - P. 932-935. 164. Teloken C. Therapeutic effects of high dose yohimbine hydrochlo-ride on organic erectile dysfunction / C. Teloken, E.L. Rhoden, P. Sogari [et al.] // J. Urol. - 1998. - Vol. 159, N 1. - P. 122-124. 165. Thadani U. The effect of vardenafil, a potent and highly selective phosphodiesterase-5 inhibitor for the treatment of erectile dysfunction, on the cardiovascular response to exercise in patients with coronary artery disease / U. Thadani, W. Smith, S. Nash [et al.] //J. Amer. Coll. Cardiol. - 2002. - Vol. 40, N 11. - P. 2006-2012. 166. Travison T.G. The natural progression and remission of erectile dysfunction: results from the Massachusetts Male Aging Study / T.G. Travison, R. Shabsigh, A.B. Araujo [et al.] // J. Urol. - 2007. -Vol. 177, N1.-P. 241-246. 167. Vardi Y. Effects of sildenafil citrate (Viagra) on hemodynamic parameters during exercise testing and occurrence of ventricular arrhythmias in patients with erectile dysfunction and cardiovascular disease / Y. Vardi, M. Bulus, S. Reisner [et al.] // Europ. Urol. - 2003. -Vol. 43,N 5. -P. 544-551. 168. Vardi Y. Logistic regression and survival analysis of 450 impotent patients treated with injection therapy: long-term dropout parameters / Y. Vardi, E. Sprecher, IJ. Gruenwald // Urology. - 2000. - Vol. 163, N2.-P. 467-470. 169. Virag R. Intracavernous injection of papaverine for erectile failure // Lancet. - 1982. - Vol. 23, N 2. - P. 938. 170. Webster LJ. Use of sildenafil for safe improvement of erectile function and quality of life in men with New York Heart Association classes П and III congestive heart failure: a prospective, placebocontrolled, double-blind crossover trial / L J. Webster, E.D. Michelakis, T. Davis, S.L. Archer // Arch. Intern. Med. - 2004. -Vol. 164,N5.-P. 514-520. 171. Wespes E. Guidelines on erectile dysfunction / E. Wespes, E. Amar, D. Hatzichristou [et al.] // Europ. Urol. - 2002. - Vol. 41, N l.-P. 1-5. 172. Wespes E. Guidelines on erectile dysfunction / E. Wespes, E. Amar, D.G. Hatzichristou [et al.]. - Amsterdam : European Association of Urology, 2006. - 27 p. 173. Wespes E. Age related changes in the quantification of the intra-cavernous smooth muscle in potent men / E. Wespes, P. Moreira de Goes, C.C. Schulman // J. Urol. - 1998. - Vol. 159. - P. 99 (abstract). 174. Wespes E. Sildenafil non-responders: haemodynamic and mor-phometric studies / E. Wespes, A. Rammal, С Garbar // Europ. Urol. -2005.-Vol. 48,N l.-P. 136-139. 175. Wespes E. Venous impotence: pathophysiology, diagnosis and treatment / E. Wespes, С Schulman // J. Urol. - 1993. - Vol. 149, N 5, pt.2.-P. 1238-1245. 176. Williams J.M.G. Cry of pain: understanding suicide and self-harm / J.M.G. Williams. - London : Penguin, 1997. - 188 p. 177. Wilson S.K. Penile prosthesis implantation: pearls, pitfalls and perils // Male infertility and sexual dysfunction / ed. W.J.C. Hellstrom. -New York, 1997.-P. 545. 178. Wilson S.K. Status of penile implants : AUA postgraduate course HO 231 PG. - Baltimore : AUA Annual Meeting, 2002. - 48 p. 179. Wilson S.K. Comparison of mechanical reliability of original and enhanced Mentor Alpha I penile prostheses / S.K. Wilson, M.A. Cleves, D.R. Delk // J. Urol. - 1999. - Vol. 162, N 3. - P. 715-718. 180. Wilson S.K. Inflatable penile implant infection: predisposing factors and treatment suggestions / S.K. Wilson, J.R. Delk // Management of complex penile implant cases Symposium : AUA Annual Meeting handbook. - Baltimore, 1995. - 53 p. 181. Wilson S.K. Penile implants / S.K. Wilson, J. Mulcahy // Male sexual function / ed by J J. Mulcahy. -Totowa (N. J.) : Humana Press Inc., 2006.-Chap. 16.-P. 331-380. 182. Yassin A.A., Saad F., Traish A. Alfuzosin combined with tadalafil improves tadalafil response. Presentation at: The 6th Congress of European Society of Sexual Medicine, November 16-19, 2003, Istanbul, Turkey. 183. Zhou S.H. Role of female partners in the diagnostics and treatment of erectile dysfunction / S.H. Zhou, J.X. Xie, M. Chen [et al.] // Zhonghua Nan Ke Xue. - 2006. - Vol. 12, N.5. - P. 473-476. Живов А.В. Оценка влияния лечения эректильной дисфункции на качество жизни больных Похожие материалы Дата публикации: 15 января 2017 . |
|
|
